Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller at Pfizer, reported the acquisition of 54 phantom stock units through the Pfizer Supplemental Savings Plan on June 28, 2024.

Summary

• On June 28, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 54 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• These units are settled in cash following the reporting person's separation from service and can be transferred into an alternative investment account at any time.
• The price of the underlying common stock for these units is $27.98.
• Following this transaction, Damico directly owns 28,525 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of phantom stock units can be seen as a positive sign, but it's a routine part of executive compensation.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock.

Future Outlook

The phantom stock units will be settled in cash following the reporting person's separation from service.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that a high-ranking executive is accumulating more company stock, which can be seen as a positive sign.

Comparison to Industry Standards

• Phantom stock plans are a common form of executive compensation in large publicly traded companies like Pfizer.
• Companies such as Johnson & Johnson (JNJ) and Merck (MRK) also utilize similar deferred compensation plans to incentivize their executives.
• The specific terms of these plans, such as vesting schedules and settlement methods, can vary widely across companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.
• Employees may view this as a positive sign of executive confidence in the company.

Key Dates